SPECLIPSE
Speclipse is a transformative, patented technology for real-time, non-invasive, in-vivo cancer diagnosis utilizing laser spectroscopy and machining learning algorithms.
SPECLIPSE
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2015-01-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.speclipse.com
Total Employee:
1+
Status:
Active
Contact:
82-31-698-2269
Email Addresses:
[email protected]
Total Funding:
10.24 M USD
Technology used in webpage:
Domain Not Resolving Euro Mobile Non Scaleable Content IPv6 Apache Google Google Cloud Apache 2.4 Amazon S3 Amazon Route 53
Similar Organizations
Atoplex
Atoplex is a home test system and diagnosis platform using molecular immunodiagnosis technology.
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
Healthily
Healthily is the world’s first medically approved self-care app designed around you.
Zebra Medical Vision
Zebra Medical Vision is a medical imaging and analytics platform.
Current Employees Featured
Founder
Investors List
Shinhan Capital
Shinhan Capital investment in Venture Round - Speclipse
Signite Partners
Signite Partners investment in Venture Round - Speclipse
BNH
BNH investment in Venture Round - Speclipse
Devsisters Ventures
Devsisters Ventures investment in Venture Round - Speclipse
MiCo
MiCo investment in Venture Round - Speclipse
SBVA
SBVA investment in Venture Round - Speclipse
Mega Investment
Mega Investment investment in Venture Round - Speclipse
TIPS Program
TIPS Program investment in Pre Seed Round - Speclipse
Official Site Inspections
http://www.speclipse.com Semrush global rank: 14.03 M Semrush visits lastest month: 63
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Speclipse"
Speclipse - Crunchbase Company Profile & Funding
Speclipse is a laser-based medical diagnostic technology. Speclipse is a transformative, patented technology for real-time, non-invasive, in-vivo cancer …See details»
Speclipse, Inc. - LinkedIn
Speclipse, Inc., is the medical device developer of the world’s first cancer diagnostic solution based on laser-induced plasma spectroscopy (LIPS) and artificial intelligence (AI) technology.See details»
Speclipse - Detect the Invisible in an Instant
USA Speclipse, Inc. - 310 De Guigne Drive, Sunnyvale, CA 94085, USA. South Korea Speclipse, Inc. (Head Office) - 4th Floor, Gyeongchang Building, 141, Unjung-ro ...See details»
Speclipse 2025 Company Profile: Valuation, Investors ... - PitchBook
Speclipse General Information Description. Developer of a medical diagnostic platform intended to detect early symptoms of skin cancer, including melanoma. The company's platform uses …See details»
Speclipse - Funding, Financials, Valuation & Investors - Crunchbase
Speclipse is a laser-based medical diagnostic technology. How much funding has this organization raised over time? ShowSee details»
Speclipse Company Profile | Management and Employees List
Speclipse Profile and History. Established in 2015, headquartered in Sunnyvale, California, based out of Seuol, South Korea, Speclipse was founded by Sung Hyun Pyun, a graduate of …See details»
Speclipse - Products, Competitors, Financials, Employees, …
About Speclipse. Speclipse is a medical device company focused on dermatological diagnostics and treatments. The company offers non-invasive, real-time diagnostic solutions for skin …See details»
Speclipse - Craft
Speclipse is a company developing laser-based diagnostic tools. It offers the technology for real-time, non-invasive, in-vivo skin cancer diagnosis utilizing laser spectroscopy and machining …See details»
Speclipse - Company Profile - Tracxn
Oct 31, 2024 Speclipse - Provider of molecular spectroscopy systems for early-stage skin cancer detection. Acquired by Cellreturn. Raised a total funding of $10.6M over 2 rounds from …See details»
Speclipse - VentureRadar
Similar Companies: DAMAE MEDICAL France Privately Held Damae Medical specializes in developing cutting-edge imaging systems for skin condition diagnosis. Their flagship product, …See details»
Speclipse I Patients
USA Speclipse, Inc. - 310 De Guigne Drive, Sunnyvale, CA 94085, USA. South Korea Speclipse, Inc. (Head Office) - 4th Floor, Gyeongchang Building, 141, Unjung-ro ...See details»
Speclipse - Overview, News & Similar companies | ZoomInfo.com
Oct 20, 2021 Who is Speclipse. Established in 2015, headquartered in Sunnyvale, California, based out of Seuol, South Korea, Speclipse was founded by Sung Hyun Pyun, a graduate o f …See details»
South Korea - imcas.com
Speclipse, Inc. founded by Stanford graduates and a dermatologist, has developed a transformative, patented technology for real-time, non-invasive, in vivo cancer diagnosis based …See details»
Speclipse I Science
USA Speclipse, Inc. - 310 De Guigne Drive, Sunnyvale, CA 94085, USA. South Korea Speclipse, Inc. (Head Office) - 4th Floor, Gyeongchang Building, 141, Unjung-ro ...See details»
Speclipse | Non Invasive Device Solutions Company-2021
In 2020, MedTech Outlook Magazine sat down with Dr. Sung Hyun Pyun, CEO of Speclipse, to discuss the medical device developer’s patented non-invasive, in-vivo cancer diagnostic solution.See details»
Speclipse - Raised $10.6M Funding from 11 investors - Tracxn
Mar 2, 2025 Speclipse has raised a total funding of $10.6M over 2 rounds from 11 investors. Investors include SBVA, InterVest and 9 others. Their latest funding round was of $8M on Aug …See details»
Speclipse attracts $7.7M in investments with its laser spectroscopic ...
Aug 19, 2021 Speclipse, which began as a developer of cancer diagnosis devices, was founded in 2015 by a group of master and doctorate degree holders from Stanford University in the …See details»
Speclipse, Inc. | Top Dermatology Solution Company-2018
While add-on Spectra-Scope ® is desgined to be mounted on existing commercially avaiable athesthetic laser equipment, the stand-alone model, consisting of a laser and an analysis …See details»
Speclipse included in MedTech Outlook rating of top 10 non …
Oct 21, 2021 Speclipse, which began as a developer of cancer diagnostic devices, was founded in 2015 by a group of Stanford University master's and Ph.D. degree holders. Its first product, …See details»
News (EN) (All) | Speclipse Dx
Mar 18, 2020 Speclipse, Inc., a World leading LIPS and A.I. based medical diagnostic company and the developer of the Spectra-Scope, providing instant, scar-free but highly accurate …See details»